Oligomeric peptides and their use for the treatment of HIV infections

Details for Australian Patent Application No. 2005254736 (hide)

Owner IPF Pharmaceuticals GmbH

Inventors Kirchhoff, Frank; Forssmann, WolfGeorg; Schulz, Axel; Adermann, Knut; Munch, Jan

Agent Davies Collison Cave

Pub. Number AU-B-2005254736

PCT Pub. Number WO2005/123771

Priority 60/675,861 29.04.05 US; 60/580,384 18.06.04 US; 04014304.2 18.06.04 EP

Filing date 17 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 18 August 2011

International Classifications

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 38/57 (2006.01) Medicinal preparations containing peptides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123771 Priority application(s): WO2005/123771

18 August 2011 Application Accepted

  Published as AU-B-2005254736

6 October 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 14 Sep 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254740-Curing agents for epoxy resins

2005254734-Production of polypeptides by improved secretion